While 2HG accumulation is linked to oncogenic processes resulting from IDH mutations found in astrocytomas and other cancers [17,18], in glioblastomas, this absence correlates with increased aggressiveness and therapy resistance [19], although the underlying mechanisms remain poorly understood. This evidence concerns the gene IDH1 and glioblastoma.